Biotech entity
All 2 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 2 also mention Aedes albopictus, the most common co-covered peer. The 120-day window averages about 0.1 stories each week. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline.
Last mentioned: Jun 18, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 2 also mention Aedes albopictus, the most common co-covered peer. The 120-day window averages about 0.1 stories each week. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline. Their average consequence score of 7 runs above the beat's 6.1 for that window. We currently track 2 Biotech stories that mention European Medicines Agency (EMA), published between February 19, 2026 and June 18, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 482 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering European Medicines Agency (EMA). Shared-story counts are live from our verified record — not editorial picks.
With zero critical findings on its fourth EMA GMP certification, WuXi Biologics now empowers 13 biotech clients to commercialize 19 biologics in Europe. This milestone validates the company's integrated CRDMO model and deepens its competitive moat in the biologics CDMO space.
Source: prnewswire.com · pannaphat.me
A landmark study reveals that the excruciating tropical disease Chikungunya is now capable of local transmission across most of Europe. Driven by the northward migration of the Aedes albopictus mosquito, this shift creates an urgent demand for vaccines and diagnostic infrastructure in previously unaffected regions.
Source: theguardian.com · aol.co.uk
European Medicines Agency (EMA) is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
